Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein

August 2005
Croatian Medical Journal;2005, Vol. 46 Issue 4, p717
Academic Journal
Presents an abstract of the study "Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein," by M. Hasan et al.


Related Articles

  • Cyclophosphamide.  // Reactions Weekly;4/14/2012, Issue 1397, p13 

    The article describes the case of a 63-year-old woman with melena and gastric pain who developed Serum cytomegalovirus (CMV) after receiving cyclophosphamide pulse therapy for dermatomyositis.

  • Cytomegalovirus.  // ASHA;Nov94, Vol. 36 Issue 11, p64 

    Focuses on the cytomegalovirus, the leading viral cause of hearing loss in newborn infants. Diagnosis; Transmission; Sources of infection; Complications.

  • Human Cytomegalovirus in Oral Squamous Cell Carcinoma in Southeast of Iran. Saravani, Shirin; Kadeh, Hamideh; Miri-Moghaddam, Ebrahim; Zekri, Ali; Sanadgol, Nima; Gholami, Aliye // Jundishapur Journal of Microbiology;Aug2015, Vol. 8 Issue 8, p1 

    Background: Carcinogenesis is a multi-step process and the role of infectious agents in this progression has not been fully identified. Since human cytomegalovirus (HCMV) is frequently presented in the gingival sulcus fluid, we hypothesized that this virus would be important in the pathogenesis...

  • Eye implant releases drugs. Edelson, Edward // Popular Science;Sep93, Vol. 243 Issue 3, p31 

    Discusses cytomegalovirus (CMV), an eye-infecting virus that can cause blindness. Current treatment; New implant developed at the University of Kentucky that makes treatment more effective and considerably less stressful; How implant works.

  • Late Intrauterine Cytomegalovirus (CMV) Infection: Clinical and Neuroimaging Findings. J.B.B.; Lampe, John B. // Clinical Pediatrics;Jul1997, Vol. 36 Issue 7, p431 

    Presents a review of the study `Late Intrauterine Cytomegalovirus (CMV) Infection: Clinical and Neuroimaging Findings,' by M.I. Steinlin, D. Nadal et al. published in `Pediatric Neurology' in 1996. Prevalence rate of CMV infections in newborns; Diagnostic procedures; Treatment.

  • In This Issue.  // Kidney International;Oct2007, Vol. 72 Issue 8, p905 

    The article discusses various reports published within the issue, including one about epithelial mesenchymal transition and another regarding the economic impact of cytomegalovirus.

  • Mutations Conferring Ganciclovir Resistance in a Cohort of Patients with Acquired Immunodeficiency Syndrome and Cytomegalovirus Retinitis. Jabs, Douglas A.; Martin, Barbara K.; Forman, Michael S.; Dunn, J. P.; Davis, Janet L.; Weinberg, David V.; Biron, Karen K.; Baldanti, Fausto // Journal of Infectious Diseases;1/15/2001, Vol. 183 Issue 2, p333 

    Provides information on a study which identified patients with cytomegalovirus (CMV) retinitis having a phenotypic or genotypic ganciclovir-resistant isolate. Background information on CMV; Methodology; Results; Conclusions.

  • Infliximab/steroids.  // Reactions Weekly;8/18/2012, Issue 1415, p27 

    The article describes the case of a 63-year-old woman with gastric ulcer who developed a secondary cytomegalovirus (CMV) infection after receiving infliximab and steroids.

  • fomivirsen sodium:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p93 

    A definition of the term "Fomivirsen Sodium," which refers to a drug used to treat cytomegalovirus retinitis, administered by injecting directly into the eye, is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics